Semmax Financial Advisors Inc. Bristol Myers Squibb CO Transaction History
Semmax Financial Advisors Inc.
- $351 Million
- Q1 2025
A detailed history of Semmax Financial Advisors Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 110 shares of BMY stock, worth $5,142. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110
Previous 91
20.88%
Holding current value
$5,142
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BMY
# of Institutions
2,801Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.95 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.42 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.05 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.43 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...